BetaEntity Annotation Prototype

Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed

All extracted treatments

Showing 541–600 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

Locoregional therapy3Pancreatic Enzyme Replacement Therapy3Peroral endoscopic myotomy3Pharmacologic treatment3Positive Airway Pressure (PAP) therapy3Regional analgesia3Traditional Chinese Medicine3Vitamin supplementation3advanced therapies3anti-PD1 therapy3anti-VEGF therapy3anti-programmed cell death protein-1 therapy3antiarrhythmic therapy3anticancer therapies3anticancer therapy3autologous stem cell transplantation3behavioural therapy3cancer therapies3chimeric antigen receptor T-cell therapy3clinical management3cognitive–behavioural therapy3conventional immunosuppression3coronary revascularisation3deworming3diabetes treatment3dopaminergic therapy3haematopoietic stem cell transplantation3immunotherapy treatment3inhaled corticosteroids3intensive care treatment3intravenous fluid therapy3intravenous iron therapy3lethal palliation3lifestyle changes3local anaesthesia3neurocritical care3novel therapies3nutritional support3occupational therapy3oral antibiotics3outpatient treatment3palliative chemotherapy3pharmacological interventions3physical rehabilitation3preventive measures3standard therapy3standard treatment3stent retriever thrombectomy3supportive treatment3surgical interventions3surgical management3symptomatic therapy3targeted treatment3topical therapy3tracheostomy3tyrosine kinase inhibitors3ultrasound-guided nerve blocks3vasodilator therapy3vasopressors3ventriculoperitoneal shunting3
View all 4,719 treatments on one page

Articles mentioning treatments

7,227 articles · page 389 of 603
77.0%
alternative therapiesHyperkalaemiaSodium zirconium cyclosilicateSZCNational Institute for Health and Care ExcellenceNICENICE

…4–48 hours. If serum potassium remains elevated after 72 hours, alternative therapies should be considered, due to the increased risk of electrolyte …

86.6%
Antifibrotic therapynintedanibmycophenolateidiopathic pulmonary fibrosistertiary hospitalDiffuse interstitial lung diseases (DILD)sclerodermaPFLDIPFprogressive fibrosing lung disease (PFLD)

…, may evolve into a fibrotic phenotype with functional decline. Antifibrotic therapy, particularly nintedanib, has significantly improved management…